Tuesday - November 5, 2024
Wyden Urges ADHD Drug Manufacturers to Boost Production or Relinquish Excess Quota to Help Shortage
August 04, 2023
WASHINGTON, Aug. 4 -- Sen. Ron Wyden, D-Oregon, issued the following news release and letter on Aug. 3, 2023:

U.S. Senator Ron Wyden, D-Ore., today urged manufacturers of much-needed amphetamine medications for attention deficit hyperactivity disorder (ADHD), including Adderall and generic equivalents, to either increase their manufacturing of these medications or relinquish their remaining quota allotment for the Drug Enforcement Agency (DEA) to redistribute to manufacturers wantin . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your
Affiliation
Government Newspaper / Media Business
Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions
or comments:

Click here for more information about our products

Click here for more information about our products